CircRNA_103801 accelerates proliferation of osteosarcoma cells by sponging miR-338-3p and regulating HIF-1/Rap1/PI3K-Akt pathway

ZQ Li, Z Wang, Y Zhang, C Lu, QL Ding, R Ren, BB Cheng, LX Lou

Article ID: 3992
Vol 35, Issue 3, 2021
DOI: https://doi.org/10.23812/20-725-A
Received: 9 July 2021; Accepted: 9 July 2021; Available online: 9 July 2021; Issue release: 9 July 2021

Abstract

This study aimed to investigate the roles of hsa_circRNA_103801 in the progression of osteosarcoma (OS) cells. Quantitative reverse transcription-polymerase chain reaction (RT-qPCR) was used to detect the expression level of circRNA_103801 in OS cells. Cell count kit-8 and Transwell migration and invasion assays were employed to detect the proliferation, migration, and invasion abilities of OS cells. The effects of circRNA_103801 on the apoptosis of OS cells were identified by flow cytometry. The binding relationship between circRNA_103801 and miR-338-3p was verified by bioinformatics analysis. MiR-338-3p level in OS cell lines was detected by RT-qPCR. Additionally, Western blotting was utilized to detect the expression levels of HIF-1, Rap1, PI3K, and Akt in OS cells. The results showed that the expression level of circRNA_103801 was significantly up-regulated in OS patients tissues. Inhibiting the expression level of circRNA_103801 could attenuate the proliferation, migration, and invasion abilities of OS cells. In addition, the down-regulated expression level of circRNA_103801 could induce cell apoptosis. The results of the luciferase reporter assay suggested that circRNA_103801 could be combined with miR-338-3p, and the RT-qPCR revealed that the miR-338-3p level in OS cells after knockdown of circRNA_103801 was elevated compared with the control group. The results of Western blotting suggested that the expression levels of HIF-1, Rap1, PI3K, and Akt were elevated in OS cells. In conclusion, the circRNA_103801-miR-3388-3p-HIF-1/Rap1/PI3K-Akt pathway could be a therapeutic target of OS.


Keywords

PI3K-Akt;circRNA_103801;miR-3388-3p;osteosarcoma


References

Supporting Agencies



Copyright (c) 2021 ZQ Li, Z Wang, Y Zhang, C Lu, QL Ding, R Ren, BB Cheng, LX Lou




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).